ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $198.99 -1.86%
EPS Growth %: +13.3%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
UBAB, LOAN, FITB, More
EPS Growth %: +13.3%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.20, $0.15 better than the analyst estimate of $2.05. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.19 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Our Bond (OBAI) files for 10M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
